Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research

Huntington Disease Clinical Trial

Official title:

Project AWARE 2.0 to Improve Awareness, Willingness and Ability for Research and Enrollment in Clinical Research

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06343220
• Other study ID #: AWARE 2.0
• Status: Recruiting
• Start date: April 10, 2024
• Est. completion date: September 2024

Study information

• Verified date: April 2024
• Source: Huntington Study Group
• Contact: Elise Kayson, MS
• Phone: 800-487-7671
• Email: info[@]myhdstory.org
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The Project AWARE 2.0 Survey is intended to gain knowledge about the feelings, attitudes, and beliefs of HD family members, care partners and others affected by HD towards the way drug trials and observational studies are communicated and conducted.

Description:

The Project AWARE 2.0 Survey will be offered to HD families via HSG's online platform called myHDstory®. The survey will obtain input and knowledge about their feelings, attitudes, and beliefs concerning clinical research and the process by which HD studies are communicated and conducted. Project AWARE 2.0 is intended to provide the HD research community with the insight and tools to help (a) improve prospective research participants' awareness, willingness, and ability to participate in clinical research for HD; and (b) design clinical studies and trials in the future.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 600
• Est. completion date: September 2024
• Est. primary completion date: September 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participants must either have HD or be at risk for having HD

• Participants must be 18 years of age or older

• Participants must live in the United States

• Inclusion of participants will not be based on race, gender, or ethnicity.

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Huntington Disease

Locations

Country	Name	City	State
United States	Huntington Study Group	Rochester	New York

Sponsors (2)

Lead Sponsor	Collaborator
Huntington Study Group	Roche Products Limited

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Examine awareness	To examine prospective research participants' awareness, willingness, and ability to participate in clinical research for HD.	December 2024
Primary	Provide the HD research community with the insight.	Provide the HD research community with insight to design clinical studies and trials in the future.	December 2024